Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02339220 · ClinicalTrials.gov registry record · NA
The Brave Initiative: Bringing Rehabilitation to American Veterans in an Enriched Environment
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT02339220 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 42 participants.
The verdict
NCT02339220, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the value of Constraint-Induced Movement therapy (CIMT) for improving motor function and general fitness in adults with subacute and chronic traumatic brain injury (TBI), particularly TBI acquired during active military duty, in comparison to a Lakeshore Enriched Fitness Training (LEFT). The study will also test the effect of a set of enhanced versus "standard" procedures for transferring therapeutic gains from treatment setting to everyday life. Lastly, this study will determine whether any therapeutic effects observed are correlated with neuroplastic white matter or grey matter changes.
Interventions
- BEHAVIORAL Constraint-Induced Movement Therapy (CIMT)
- BEHAVIORAL Lakeshore Enriched Fitness Training (LEFT)
- BEHAVIORAL standard Transfer Package (sTP)
- BEHAVIORAL enhanced Transfer Package (eTP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2016-09 |
| Est. Completion | 2019-04-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02339220
The ClinicalTrials.gov registry entry for NCT02339220 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Constraint-Induced Movement Therapy (CIMT) is the first listed.
NCT02339220 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02339220 about?
NCT02339220 is a clinical study titled "The Brave Initiative: Bringing Rehabilitation to American Veterans in an Enriched Environment". The purpose of this study is to determine the value of Constraint-Induced Movement therapy (CIMT) for improving motor function and general fitness in adults with subacute and chronic traumatic brain injury (TBI), particularly TBI acquired during active military duty, in comparison to a Lakeshore Enr...
What is the current status of trial NCT02339220?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2016-09. Estimated completion is 2019-04-24.
What interventions are being tested in trial NCT02339220?
The interventions under investigation include: Constraint-Induced Movement Therapy (CIMT) (BEHAVIORAL), Lakeshore Enriched Fitness Training (LEFT) (BEHAVIORAL), standard Transfer Package (sTP) (BEHAVIORAL), enhanced Transfer Package (eTP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02339220?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.